Clinical Trial

Development of an Online ACT Intervention for Disorders of Gut-Brain Interaction

Study acronym: iACTforDGBI
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to develop and test the iACTforDGBI intervention in a sample of Swedish individuals with DGBI (Disorders of Gut-Brain Interaction). The first substudy of this project (Substudy 1) aims to answer the following question: How can the design of iACTforDGBI be tailored to meet the specific needs of individuals with DGBI and clinically meaningful symptoms of anxiety and depression? Participants (individuals with symptoms compatible with a DGBI and anxiety and/or depression, and healthcare professionals working with DGBI patients) will be asked to participate in online focus-group interviews and provide information on their views of a preliminary version of the iACTforDGBi intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-07.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-08-11
Trial Details
NCT Number NCT06309004
Lead Sponsor Örebro University, Sweden
Collaborators: Uppsala University, SahlgrenskaUniversityHospital, Göteborg University
Conditions Anxiety and Depression, Disorders of Gut-brain Interaction
Enrollment 15 participants
Start Date 2024-09-23
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-15